These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19193011)

  • 1. Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors.
    Huang H; Hutta DA; Rinker JM; Hu H; Parsons WH; Schubert C; DesJarlais RL; Crysler CS; Chaikin MA; Donatelli RR; Chen Y; Cheng D; Zhou Z; Yurkow E; Manthey CL; Player MR
    J Med Chem; 2009 Feb; 52(4):1081-99. PubMed ID: 19193011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel FMS kinase inhibitors as anti-inflammatory agents.
    Illig CR; Chen J; Wall MJ; Wilson KJ; Ballentine SK; Rudolph MJ; DesJarlais RL; Chen Y; Schubert C; Petrounia I; Crysler CS; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Meegalla SK
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1642-8. PubMed ID: 18242992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents.
    Patch RJ; Brandt BM; Asgari D; Baindur N; Chadha NK; Georgiadis T; Cheung WS; Petrounia IP; Donatelli RR; Chaikin MA; Player MR
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6070-4. PubMed ID: 17904845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors.
    Wall MJ; Chen J; Meegalla S; Ballentine SK; Wilson KJ; DesJarlais RL; Schubert C; Chaikin MA; Crysler C; Petrounia IP; Donatelli RR; Yurkow EJ; Boczon L; Mazzulla M; Player MR; Patch RJ; Manthey CL; Molloy C; Tomczuk B; Illig CR
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2097-102. PubMed ID: 18289848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based optimization of a potent class of arylamide FMS inhibitors.
    Meegalla SK; Wall MJ; Chen J; Wilson KJ; Ballentine SK; Desjarlais RL; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Illig CR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3632-7. PubMed ID: 18495479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors.
    Huang H; Hutta DA; Hu H; DesJarlais RL; Schubert C; Petrounia IP; Chaikin MA; Manthey CL; Player MR
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2355-61. PubMed ID: 18342505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors.
    Illig CR; Manthey CL; Meegalla SK; Wall MJ; Chen J; Wilson KJ; DesJarlais RL; Ballentine SK; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Donatelli RR; Yurkow E; Zhou Z; Player MR; Tomczuk BE
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6363-9. PubMed ID: 24138939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
    J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors.
    Wilson KJ; Illig CR; Chen J; Wall MJ; Ballentine SK; DesJarlais RL; Chen Y; Schubert C; Donatelli R; Petrounia I; Crysler CS; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Meegalla SK
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3925-9. PubMed ID: 20570147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.
    Conway JG; Pink H; Bergquist ML; Han B; Depee S; Tadepalli S; Lin P; Crumrine RC; Binz J; Clark RL; Selph JL; Stimpson SA; Hutchins JT; Chamberlain SD; Brodie TA
    J Pharmacol Exp Ther; 2008 Jul; 326(1):41-50. PubMed ID: 18434589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141).
    Illig CR; Manthey CL; Wall MJ; Meegalla SK; Chen J; Wilson KJ; Ballentine SK; Desjarlais RL; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Donatelli RR; Yurkow E; Zhou Z; Player MR; Tomczuk BE
    J Med Chem; 2011 Nov; 54(22):7860-83. PubMed ID: 22039836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain.
    Walter M; Lucet IS; Patel O; Broughton SE; Bamert R; Williams NK; Fantino E; Wilks AF; Rossjohn J
    J Mol Biol; 2007 Mar; 367(3):839-47. PubMed ID: 17292918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model.
    Ohno H; Uemura Y; Murooka H; Takanashi H; Tokieda T; Ohzeki Y; Kubo K; Serizawa I
    Eur J Immunol; 2008 Jan; 38(1):283-91. PubMed ID: 18085662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
    Hannig G; Bernier SG; Hoyt JG; Doyle B; Clark E; Karp RM; Lorusso J; Westlin WF
    Arthritis Rheum; 2007 Mar; 56(3):850-60. PubMed ID: 17328059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel anilinoquinolines as c-fms inhibitors.
    Smalley TL; Chamberlain SD; Mills WY; Musso DL; Randhawa SA; Ray JA; Samano V; Frick L
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6257-60. PubMed ID: 17870531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted N-aryl-6-pyrimidinones: a new class of potent, selective, and orally active p38 MAP kinase inhibitors.
    Devadas B; Selness SR; Xing L; Madsen HM; Marrufo LD; Shieh H; Messing DM; Yang JZ; Morgan HM; Anderson GD; Webb EG; Zhang J; Devraj RV; Monahan JB
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3856-60. PubMed ID: 21620699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
    Gillooly KM; Pattoli MA; Taylor TL; Chen L; Cheng L; Gregor KR; Whitney GS; Susulic V; Watterson SH; Kempson J; Pitts WJ; Booth-Lute H; Yang G; Davies P; Kukral DW; Strnad J; McIntyre KW; Darienzo CJ; Salter-Cid L; Yang Z; Wang-Iverson DB; Burke JR
    J Pharmacol Exp Ther; 2009 Nov; 331(2):349-60. PubMed ID: 19652024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro.
    Brownlow N; Vaid M; Dibb NJ
    Leukemia; 2008 Jul; 22(7):1452-3. PubMed ID: 18185521
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists.
    Didiuk MT; Griffith DA; Benbow JW; Liu KK; Walker DP; Bi FC; Morris J; Guzman-Perez A; Gao H; Bechle BM; Kelley RM; Yang X; Dirico K; Ahmed S; Hungerford W; DiBrinno J; Zawistoski MP; Bagley SW; Li J; Zeng Y; Santucci S; Oliver R; Corbett M; Olson T; Chen C; Li M; Paralkar VM; Riccardi KA; Healy DR; Kalgutkar AS; Maurer TS; Nguyen HT; Frederick KS
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4555-9. PubMed ID: 19625189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.